Compounds > 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Page last updated: 2024-10-21

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Chronic Insomnia

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Chronic Insomnia in 1 studies

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.

Research Excerpts

ExcerptRelevanceReference
"Of these, the most common is insomnia, the difficulty to initiate and maintain sleep."1.56Basal ganglia beta oscillations during sleep underlie Parkinsonian insomnia. ( Bergman, H; Deffains, M; Israel, Z; Kaplan, A; Mizrahi-Kliger, AD, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Mizrahi-Kliger, AD1
Kaplan, A1
Israel, Z1
Deffains, M1
Bergman, H1

Other Studies

1 other study available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Chronic Insomnia

ArticleYear
Basal ganglia beta oscillations during sleep underlie Parkinsonian insomnia.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 07-21, Volume: 117, Issue:29

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Basal Ganglia; Beta Rhythm; Cerebral Cortex;

2020